Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries

Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries

Item
http://www.wikidata.org/entity/Q34726506
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK.Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database studyReal-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study.Relationship of body mass index with efficacy of exenatide twice daily added to insulin glargine in patients with type 2 diabetes.Evaluating the Long-Term Cost-Effectiveness of Daily Administered GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes in the United Kingdom.GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom.Evaluation of the long-term cost-effectiveness of liraglutide vs lixisenatide for treatment of type 2 diabetes mellitus in the UK setting.The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2.Anagliptin increases insulin-induced skeletal muscle glucose uptake via an NO-dependent mechanism in mice.Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France.Real-world clinical outcomes and predictors of glycaemic and weight response to exenatide once weekly in patients with type 2 diabetes: The CIBELES project.Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study.
P2860

Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries

Item
http://www.wikidata.org/entity/Q34726506
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Glucagon-like Peptide-1 recept ...... ents in six European countries
@ast
Glucagon-like Peptide-1 recept ...... ents in six European countries
@en
Glucagon-like Peptide-1 recept ...... ents in six European countries
@nl
type
label
Glucagon-like Peptide-1 recept ...... ents in six European countries
@ast
Glucagon-like Peptide-1 recept ...... ents in six European countries
@en
Glucagon-like Peptide-1 recept ...... ents in six European countries
@nl
prefLabel
Glucagon-like Peptide-1 recept ...... ents in six European countries
@ast
Glucagon-like Peptide-1 recept ...... ents in six European countries
@en
Glucagon-like Peptide-1 recept ...... ents in six European countries
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Glucagon-like Peptide-1 recept ...... ents in six European countries
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932